Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$1.1 0.01 | 0.92%
06/28/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.09
52 Week High 4.94
52 Week Low 0.86
Avg. Daily Vol. (Mil) 0.51
Beta (3 year) -0.53
Share Related Items
Mkt Cap (Mil) 13.92
Shares Out (Mil) 12.77
Float (Mil) 6.25
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.20
Current Ratio 0.30
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.42
Price/Book 0.00
Price/Cash Flow -1.90
Per Share Data
Earnings -1.14
Sales 0.45
Book Value 0.00
Cash Flow -0.56
Business Summary
Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company has two product candidates currently in development invluding Vitaros and RayVa.
General Information
11975 El Camino Real
Suite 300
San Diego, CA 92130
Industry : Drugs
Sector: Health Care
Employees: 24
CEO: Richard W. Pascoe
Short Interest
Current Month (Mil) 1.39
Previous Month (Mil) 1.41
Short Interest Ratio (Days) 4.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -158.10
Return on Investments 98.90
Gross Margin 37.50
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases

Partner Headlines for APRI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter